摘要
IgA肾病(IgAN)又称Berger’s病,由J. Berger和Hinglais于1968年首次提出,它是全世界范围内最常见的原发性肾小球疾病,也是导致终末期肾脏病(ESRD)最常见的病因,亚洲是IgAN的高发区,在我国占肾活检患者的38%~58%,并呈逐年递增的趋势,目前IgAN的发病机制仍不清楚,但是大量研究表明IgAN的发病机制与Gd-IgA1分子的形成密切相关,因此通过无创的手段测定血清Gd-IgA1的水平,探索其与IgAN发病之间的联系至关重要,也将为IgAN的诊断、治疗提供新的思路,本文就IgAN发病机制与Gd-IgA1之间的关系进行阐述。
IgA nephropathy (IgAN) is also known as Berger’s disease. Berger and Hinglais first proposed it in 1968;it is the most common primary glomerulonephritis worldwide, and Asia is a high incidence area of IgA nephropathy, accounting for 38% to 58% of renal biopsy patients in China, and it has been increasing year by year. The pathogenesis of IgAN is still unclear, but a large number of studies have shown that the pathogenesis of IgAN is closely related to the formation of Gd-IgA1 molecules. Therefore, the level of serum Gd-IgA1 is measured by non-invasive methods to explore its pathogenesis. The relationship between them is very important and will also provide new ideas for the treatment of IgAN. This article describes the relationship between the pathogenesis of IgAN and Gd-IgA1.
出处
《临床医学进展》
2020年第5期782-786,共5页
Advances in Clinical Medicine
